Early Movers: Sirius XM Radio Inc, Repros Therapeutics Inc, CBS Corporation
2013-03-28 11:36 ET - News Release
NEW YORK, March 28, 2013 -Bestdarnpennystocks.com, one of the leaders in providing investment alerts on U.S. stocks are announcing Investment Highlights on Sirius XM Radio Inc, Repros Therapeutics Inc, CBS Corporation.Sirius XM Radio Inc (NASDAQ:SIRI) stock fell 0.32% to $3.07. Clearwire Corp said on Mar. 28 that it would draw on $80 million in financing from Sprint Nextel Corp, which is seeking to buy it. Clearwire said it would still continue talks with rival bidder Dish Network Corp but it has not changed its recommendation in favor of the Sprint deal. Sprint, already the majority owner of Clearwire, struck a deal in December to buy out the rest of the company for $2.97 per share. It also gave Clearwire the option to draw on $800 million in convertible debt in 10 monthly installments.Is SIRI a Buying Opportunity After The Recent Correction? Find Out Here http://bestdarnpennystocks.com/landing/home-aw.php?code=SIRI (OR Just copy and paste the link)Additionally, the company, on Mar. 20, announced that Blake Shelton will sit down for a Q&A session with a select group of SiriusXM listeners at the SiriusXM Music City Theatre in Nashville, TN. Moderated by SiriusXM's Storme Warren, the "Town Hall" special will include the Grammy nominated musician and coach of The Voice answering questions from the studio audience about his entire career, including his new album Based On ATrue Story, which is scheduled to be released on March 26.Repros Therapeutics Inc (NASDAQ:RPRX) stock surged 70.32% to $15.55. The company, on MA. 27, reported top-line results for the first pivotal study of Androxal, ZA-301, in the treatment of secondary hypogonadism. Results for the Intent-to-Treat population met both co-primary endpoints mandated by the FDA. The Intent-to-Treat population included all men randomized in the study whether or not they completed the study.Should Investors Buy RPRX After Today’s Solid News? Get Free Report Here http://bestdarnpennystocks.com/landing/home-aw.php?code=RPRX (OR Just copy and paste the link)Additionally, the company, on Mar. 18, announced financial results for the quarter and year ended December 31, 2012. Net loss for the three month period ended December 31, 2012, was ($8.0) million or ($0.47) per share as compared to a net loss of ($2.7) million or ($0.22) per share for the same period in 2011. Total revenues and other income increased to $3,000 for the year ended December 31, 2012 as compared to $2,000 for the same period inthe prior year.CBS Corporation(NYSE:CBS), which owns broadcast networks CBS and CW, Showtime and other international television channels, is buying JP Morgan's One Equity Partners' stake in the company.TV Guide is the company that encompasses the TV Guide Network, recently rebranded as TVGN, and TVGuide.com. If this deal is completed then CBS will become an equal partner with TV Guide co-owner Lionsgate Entertainment, which originally acquired TV Guide in February 2009 for $241.6 million.Is CBS On The Way To Hit New highs? Get Free Trend Analysis Here http://bestdarnpennystocks.com/landing/home-aw.php?code=CBS (OR Just copy and paste the link)According to report, which quotes sources, CBS will play slightly less than the $122.4 million One Equity Partners shelled out for 49 percent of TV Guide in June 2009 with an option to increase its stake by 1 percent.TV Guide has been waiting for a suitor for some time now and CBS was named as one of the prospective acquirers nearly a year back. About bestdarnpennystocks.combestdarnpennystocks.com’s team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.DisclaimerThe assembled information disseminated by bestdarnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. bestdarnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in bestdarnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.Contacts:bestdarnpennystocks.com 1419 Westwood Blvd Los Angeles, CA90024-4911 email@example.com
© 2014 Canjex Publishing Ltd. All rights reserved.